Skip to content

Clinical trials

Phase 1/2 Hodgkin Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hodgkin Disease Phase: Phase 1/2 Clear all

142 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20022
20037
20044
20057
20063
20079
20087
20095
20105
20116
20127
20139
20149
20156
20165
20177
20186
20193
20201
20212
20223
20232
20245
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed89
Terminated17
Unknown status14
Active, not recruiting10
Recruiting7
Withdrawn3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)12
Fred Hutchinson Cancer Center9
M.D. Anderson Cancer Center9
Columbia University4
Memorial Sloan Kettering Cancer Center4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
University of Washington4
Bristol-Myers Squibb3
Mayo Clinic3
Northwestern University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hodgkin Disease142
Lymphoma, Non-Hodgkin74
Lymphoma51
Leukemia, Lymphocytic, Chronic, B-Cell42
Precursor Cell Lymphoblastic Leukemia-Lymphoma42
Lymphoma, Large B-Cell, Diffuse41
Multiple Myeloma41
Lymphoma, Follicular39
Lymphoma, Mantle-Cell39
Burkitt Lymphoma33

Trials

Showing 51 to 75 of 142. Each trial links to its page on Pharma Observatory.

42 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.